Skip to Content
7 Articles
CDMO / CMO ×
Blockbuster Drug Patent Recent Expirations (2024–2031) and B2B Generic Licensing Opportunities
by PharpleQ
In the global pharmaceutical industry, the expiration of a molecule’s active compound patent is only the first hurdle. The true gateway to high-margin generic entry is navigating Formulation and Compo...
Asset Light Pharma B2B Partnerships Business Partnership CDMO / CMO Dossier Licensing - In/Out Formulation Engineering Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd.
0 20
PharpleQ-Blogs
Building Stronger Pharma Partnerships: A Practical Guide to Business Collaboration
by PharpleQ
Pharmaceutical companies operate in a complex environment where expertise, dependable execution, and clear communication matter at every stage. Strategic business collaborations can help companies add...
Asset Light Pharma Business Partnership CDMO / CMO CRO Collaboration Contract Manufacturing Healthcare Pharma Co-Development Pharma Portfolio Expansion Pharma Sourcing Partnerships Pharmaceuticals PharpleQ PharpleQ Lifesciences Pvt. Ltd. Project Coordination Regulatory Compliance Technology Transfer Third-Party Manufacturing
0 51
PharpleQ-Blogs
Clinical Personal Care at Scale: Capitalizing on India's Surging Full-Spectrum Cosmeceutical Export Engine
by PharpleQ
The global beauty and personal care industry is experiencing an unprecedented structural shift. Driven by an increasingly well-informed consumer base, market demand has permanently evolved away from t...
Asset Light Pharma CDMO / CMO Contract Manufacturing Cosmeceutical Products Formulation Engineering India’s Healthcare Market Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd. Regulatory Compliance Third-Party Manufacturing
0 49
PharpleQ-Blogs
The Technology Transfer Blueprint: Seamlessly Moving Formulations from Lab Scale to Commercial Volume
by PharpleQ
The Scale-Up Challenge: A formulation performing flawlessly inside a 2-liter glass laboratory vessel often exhibits completely different physics when scaled up to a 500-liter industrial industrial ble...
Asset Light Pharma CDMO / CMO Contract Manufacturing Formulation Engineering PharpleQ PharpleQ Lifesciences Pvt. Ltd. Regulatory Compliance Technology Transfer
0 87
PharpleQ-Blogs
Accelerating Global Market Entry: The Asset-Light Blueprint for Pharma BD Teams Facing Pipeline Gaps
by PharpleQ
Pharmaceutical Business Development (BD) managers across the globe specifically EU, US, MENA, CIS, LATAM, and ASEAN regions face an identical, high-stakes commercial challenge: the pipeline crunch . C...
Asset Light Pharma CDMO / CMO Commercial Supply Agreement Dossier Licensing - In/Out Healthcare Pharma Co-Development Pharma Portfolio Expansion Pharma Sourcing Partnerships Pharmaceuticals PharpleQ Therapeutic Nutraceuticals
0 95
PharpleQ-Blogs
CPHI - 2026 - Global Pharma Events - South East Asia, Korea, Shenzhen, Milan, India, Middle East
by PharpleQ
CPHI 2026 Global Pharma Events: Where World's Pharmaceutical Industry Connects The pharmaceutical industry continues to become more interconnected than ever before. In 2026, the CPHI Global Event Seri...
CDMO / CMO CPHI Contract Manufacturing Dossier Licensing - In/Out Healthcare Pharmaceuticals PharpleQ PharpleQ Lifesciences Pvt. Ltd. Quick. Quality. Quorum. Technology Transfer Third-Party Manufacturing
0 355
PharpleQ-Blogs
India’s Healthcare Market: A Global Growth Engine in 2026
by PharpleQ
India’s healthcare industry is rapidly emerging as one of the world’s fastest-growing and most opportunity-driven sectors. With strong advancements in pharmaceuticals, biotechnology, specialty healthc...
CDMO / CMO Contract Manufacturing Dossier Licensing - In/Out Healthcare India’s Healthcare Market Pharmaceuticals PharpleQ PharpleQ Lifesciences Pvt. Ltd. Project Coordination Quick. Quality. Quorum. Technology Transfer Third-Party Manufacturing
0 96
PharpleQ-Blogs